| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |